FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794831176> ?p ?o ?g. }

• W2794831176 endingPage "454" @default.
• W2794831176 startingPage "446" @default.
• W2794831176 abstract "Summary In trans persons on gender‐affirming hormonal treatment, a decrease (in trans women) or increase (in trans men) in hematocrit is often observed. Reference ranges for evaluation of hematocrit levels in trans persons have not been established. This prospective cohort study is part of the European Network for the Investigation of Gender Incongruence ( ENIGI ). At the Ghent and Amsterdam sites, we included 625 hormone‐naïve trans persons. Gender‐affirming hormonal treatment was initiated at the first visit. In trans men, serum hematocrit (Hct) levels increased during the first year (+4.9 Hct %, 95% CI 3.82–5.25), with the most pronounced increase during the first 3 months (+2.7 Hct %, 95% CI 1.94–3.29). Trans men receiving testosterone esters had a larger increase in serum hematocrit levels compared to trans men receiving testosterone undecanoate (Δ 0.8 Hct %). Of 192 trans men, 22 (11.5%) developed serum hematocrit levels ≥50.0%. Trans men on testosterone undecanoate were less likely to develop hematocrit levels ≥50% or ≥52%, compared to trans men on testosterone esters, and were less likely to develop hematocrit levels ≥50%, compared to trans men on testosterone gel. In trans women, serum hematocrit had dropped by 4.1 Hct % (95% CI 3.50–4.37) after 3 months, after which only small decreases were observed. In conclusion, serum hematocrit levels can be found in the reference range of the perceived gender as from 3 months after the initiation of gender‐affirming hormonal treatment." @default.
• W2794831176 created "2018-04-06" @default.
• W2794831176 creator A5008287309 @default.
• W2794831176 creator A5009949373 @default.
• W2794831176 creator A5016586194 @default.
• W2794831176 creator A5020345608 @default.
• W2794831176 creator A5026567090 @default.
• W2794831176 creator A5028160702 @default.
• W2794831176 creator A5031015917 @default.
• W2794831176 creator A5068411499 @default.
• W2794831176 creator A5072511875 @default.
• W2794831176 creator A5079676693 @default.
• W2794831176 creator A5089298275 @default.
• W2794831176 date "2018-03-30" @default.
• W2794831176 modified "2023-10-15" @default.
• W2794831176 title "Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence" @default.
• W2794831176 cites W1479924026 @default.
• W2794831176 cites W1565725283 @default.
• W2794831176 cites W1567182617 @default.
• W2794831176 cites W1572984760 @default.
• W2794831176 cites W1687146860 @default.
• W2794831176 cites W1953962102 @default.
• W2794831176 cites W1999719256 @default.
• W2794831176 cites W2002613869 @default.
• W2794831176 cites W2003562932 @default.
• W2794831176 cites W2008015557 @default.
• W2794831176 cites W2016745498 @default.
• W2794831176 cites W2018873103 @default.
• W2794831176 cites W2022939168 @default.
• W2794831176 cites W2050743117 @default.
• W2794831176 cites W2055272856 @default.
• W2794831176 cites W2055492348 @default.
• W2794831176 cites W2077474440 @default.
• W2794831176 cites W2078753971 @default.
• W2794831176 cites W2080257199 @default.
• W2794831176 cites W2091935032 @default.
• W2794831176 cites W2108872913 @default.
• W2794831176 cites W2123994640 @default.
• W2794831176 cites W2124293608 @default.
• W2794831176 cites W2142532131 @default.
• W2794831176 cites W2142563833 @default.
• W2794831176 cites W2147165437 @default.
• W2794831176 cites W2150542348 @default.
• W2794831176 cites W2156966779 @default.
• W2794831176 cites W2160971157 @default.
• W2794831176 cites W2165873164 @default.
• W2794831176 cites W2175192312 @default.
• W2794831176 cites W2175257806 @default.
• W2794831176 cites W2394924422 @default.
• W2794831176 cites W2604605537 @default.
• W2794831176 cites W2612084983 @default.
• W2794831176 cites W2612700456 @default.
• W2794831176 cites W2615527675 @default.
• W2794831176 cites W2783947535 @default.
• W2794831176 cites W4230740199 @default.
• W2794831176 cites W4236258287 @default.
• W2794831176 cites W4243829929 @default.
• W2794831176 cites W4247665917 @default.
• W2794831176 doi "https://doi.org/10.1111/andr.12485" @default.
• W2794831176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29602229" @default.
• W2794831176 hasPublicationYear "2018" @default.
• W2794831176 type Work @default.
• W2794831176 sameAs 2794831176 @default.
• W2794831176 citedByCount "70" @default.
• W2794831176 countsByYear W27948311762018 @default.
• W2794831176 countsByYear W27948311762019 @default.
• W2794831176 countsByYear W27948311762020 @default.
• W2794831176 countsByYear W27948311762021 @default.
• W2794831176 countsByYear W27948311762022 @default.
• W2794831176 countsByYear W27948311762023 @default.
• W2794831176 crossrefType "journal-article" @default.
• W2794831176 hasAuthorship W2794831176A5008287309 @default.
• W2794831176 hasAuthorship W2794831176A5009949373 @default.
• W2794831176 hasAuthorship W2794831176A5016586194 @default.
• W2794831176 hasAuthorship W2794831176A5020345608 @default.
• W2794831176 hasAuthorship W2794831176A5026567090 @default.
• W2794831176 hasAuthorship W2794831176A5028160702 @default.
• W2794831176 hasAuthorship W2794831176A5031015917 @default.
• W2794831176 hasAuthorship W2794831176A5068411499 @default.
• W2794831176 hasAuthorship W2794831176A5072511875 @default.
• W2794831176 hasAuthorship W2794831176A5079676693 @default.
• W2794831176 hasAuthorship W2794831176A5089298275 @default.
• W2794831176 hasBestOaLocation W27948311761 @default.
• W2794831176 hasConcept C126322002 @default.
• W2794831176 hasConcept C134018914 @default.
• W2794831176 hasConcept C188816634 @default.
• W2794831176 hasConcept C2779279991 @default.
• W2794831176 hasConcept C2780959883 @default.
• W2794831176 hasConcept C42407357 @default.
• W2794831176 hasConcept C71315377 @default.
• W2794831176 hasConcept C71924100 @default.
• W2794831176 hasConceptScore W2794831176C126322002 @default.
• W2794831176 hasConceptScore W2794831176C134018914 @default.
• W2794831176 hasConceptScore W2794831176C188816634 @default.
• W2794831176 hasConceptScore W2794831176C2779279991 @default.
• W2794831176 hasConceptScore W2794831176C2780959883 @default.
• W2794831176 hasConceptScore W2794831176C42407357 @default.
• W2794831176 hasConceptScore W2794831176C71315377 @default.

• next